A Divided Fed Holds Rates Steady Amid Policy Disagreement SpaceX IPO Opens to Retail Investors Through Major Brokerage Platforms US Pushes American AI Integration in Asia Following TrumpXi Meeting Senior Official Says Advent and ADIABacked Innio Targets 203 Billion Valuation in US IPO Bitcoin Ethereum Continue Decline Amid 400M Liquidations Macro and Geopolitical Headwinds Persist Pet Supplies Retailer Files for Chapter 11 Bankruptcy Amid Industry Challenges Greenidge Generation Holdings Inc GREE Q1 2025 Earnings Narrowed Loss Beats Expectations Yet Shares Slide SID Q1 2026 Earnings EPS Misses Estimates Sharply Stock Rises 547 JUNS Q4 2025 Earnings Narrower Loss Surprises Yet Stock Falls on PreRevenue Path Solidion Technology STI Q4 2025 Earnings Net Loss Widens as Stock Declines Without Revenue Disclosure Golden Entertainment Inc GDEN Q4 2025 Earnings Significant EPS Miss as Company Reports Unexpected Loss PhenixFIN Corporation PFX Q1 2026 Earnings Strong EPS Beat Driven by Investment Portfolio Stock Remains Flat Helios Technologies HLIO Surges 387 Breaking Above Key Support Zone Beyond Air Inc XAIR Faces 25 Decline as Stock Tests Key Support at 041 Beeline Holdings BLNE Edges Higher Testing Key Resistance Near 145 GlucoTrack Inc GCTK Rallies 823 as Shares Test Key Resistance Level Hingham Institution for Savings HIFS Holds Steady After Modest Gain Support and Resistance Levels in Focus Roth Capital Raises Target Price Target but Warns Q1 May Have Been a Goldilocks Quarter RELX Q2 2025 Earnings EPS Edges Past Estimates Amid Steady Performance Gen Digital GEN Holds Steady Amid Modest Decline Key Levels in Focus FRAF Q1 2026 Earnings EPS Beats Estimates by 828 Stock Rises AMTB Q1 2026 Earnings EPS Slightly Below Estimates Shares Edge Higher PRPO Q2 2025 Earnings Positive EPS Marks a Turning Point for Diagnostic Platform Worthington Steel Inc WS Q1 2026 Earnings EPS Misses Estimates Stock Still Rises AVX Q1 2026 Earnings Narrow Loss Reported Amidst Limited Disclosure Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares FTNT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable